33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 18-month efficacy and safety update from JAVELIN Merkel 200 part A: A phase II study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
    Meeting Abstract

    D'Angelo, S. P.; Russell, J. S.; Bhatia, S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • High durable CR rates and preliminary safety profile for JCAR017 in R/R aggressive b-NHL (TRANSCEND NHL 001 Study): A defined composition CD19-directed CAR T-cell product with potential for outpatient administration
    Meeting Abstract

    Abramson, J. S.; Siddiqi, T.; Palomba, M. L.; Gordon, L. I.; Lunning, M. A.; Arnason, J. E.; Wang, M.; Forero-Torres, A.; Albertson, T.; Dehner, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Characterization of genomic alterations and biomarker expression patterns of gastrointestinal cancers using a multiplatform molecular profiling tool
    Meeting Abstract

    Suero-Abreu, G. A.; Gonzalez Velez, M.; McKenna, M.; Duma, N.; Krishnasamy, S. R.; Proverbs-Singh, T. A.; Gutierrez, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • BEACON CRC study safety lead-in (SLI) in patients with BRAF(V600E) metastatic colorectal cancer (mCRC): Efficacy and tumor markers
    Meeting Abstract

    Van Cutsem, E.; Cuyle, P. J.; Huijberts, S.; Yaeger, R.; Schellens, J. H. M.; Elez, E.; Tabernero, J.; Fakih, M.; Montagut, C.; Peeters, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Postoperative proton therapy for pancreatic cancer patients enrolled on the Proton Collaborative Group (PCG) registry
    Meeting Abstract

    Nichols, R. C.; Morris, C. G.; Prabhu, K.; Hartsell, W. F.; Cahlon, O.; Apisarnthanarax, S.; McGee, L.; Vargas, C. E.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Influence of timing of surgery on perioperative morbidity after neoadjuvant therapy for locally advanced rectal cancer
    Meeting Abstract

    Roxburgh, C. S. D.; Strombom, P.; Lynn, P. B.; Paty, P.; Guillem, J. G.; Nash, G. M.; Smith, J. J.; Wei, I. H.; Garcia-Aguilar, J.; Weiser, M. R.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database
    Meeting Abstract

    Ou, F. S.; Lou, Y.; Van Cutsem, E.; Saltz, L.; Schmoll, H. J.; Goldberg, R. M.; Hoff, P.; Douillard, J. Y.; Hecht, J. R.; Hurwitz, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumour infiltrating lymphocyte expression of PD-1 as a favourable prognostic factor in patients with mismatch repair competent colorectal cancer
    Meeting Abstract

    Park, J. H.; Grant, L.; Quinn, J. A.; Roxburgh, C. S. D.; McMillan, D. C.; Edwards, J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phenotypic subtypes as a novel validated prognostic classification system for patients with colorectal cancer
    Meeting Abstract

    Roseweir, A. K.; Park, J. H.; ten Hoorn, S.; Powell, A. G. M. T.; Roxburgh, C. S. D.; McMillan, D. C.; Horgan, P. G.; Vermeulen, L.; Edwards, J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer
    Meeting Abstract

    Oh, P.; Zhang, M.; Brady, P.; Sihag, S.; Molena, D.; Ilson, D. H.; Janjigian, Y. Y.; Ku, G. Y.; Wu, A. J. C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save